Back

Efficacy and safety of ticagrelor monotherapy in patients with complex percutaneous coronary intervention: insights from the Global Leaders trial

1 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Percutaneous coronary syndrome: pharma and devices Adjunctive Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Kuniaki Takahashi

Kindai University Hospital, Osaka (Japan)

26 More presentations in this session

Presentation thumbnail
Doctor G. Gallone (Turin, IT)
Abstract Slides
Presentation thumbnail
Doctor S. Dani (Ahmedabad, IN)
Presentation thumbnail
Doctor H. Matsuda (Nagoya, JP)
Abstract Slides
Presentation thumbnail
Doctor I. Menown (Craigavon, GB)
Abstract
Presentation thumbnail
Miss L. Kerkmeijer (Zwolle, NL)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 3 - Percutaneous coronary syndrome: pharma and devices

The Event

Event poster

ESC Congress 2019

1 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Presentation
A patient with recent non-ST elevation myocardial infarction and percutaneous coronary intervention requiring cancer surgery: what do the guidelines say?
thumbnail
Congress Session
2023 ESC Guidelines for the Management of Acute Coronary Syndromes
thumbnail
Congress Session
Adjunct pharmacology in PCI: beyond antiplatelet therapy, the next chapter

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources